InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $29.790 0.46 (1.52%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,695 Form 10Q for QTR ended September 30, 2015 28 Oct 2015 9:34AM $7.800 $29.790 risen by 281.92%
$17,695 Update - Dividend/Distribution - RMD 27 Oct 2015 3:24PM $7.805 $29.790 risen by 281.68%
$17,695 Dividend/Distribution - RMD 27 Oct 2015 10:39AM $7.775 $29.790 risen by 283.15%
$17,695 ResMed Announces Results for the First Qtr of FY 2016 23 Oct 2015 8:39AM $7.740 $29.790 risen by 284.88%
$17,695 Additional proxy soliciting materials 2 Oct 2015 11:49AM $7.310 $29.790 risen by 307.52%
$17,695 Official notification of AGM (Proxy) 2 Oct 2015 11:48AM $7.310 $29.790 risen by 307.52%
$17,695 ResMed to Announce First Quarter Fiscal Year 2016 Results 25 Sep 2015 9:57AM $7.190 $29.790 risen by 314.33%
$17,695 EXCHANGE RATE FOR UPCOMING DIVIDEND PAYMENT 24 Aug 2015 10:05AM $7.210 $29.790 risen by 313.18%
$17,695 Appendix 3B 10 Aug 2015 9:40AM $7.480 $29.790 risen by 298.26%
$17,695 Form 10-K & Annual Report For the Year Ended June 30, 2015 10 Aug 2015 9:40AM $7.480 $29.790 risen by 298.26%
$17,695 Financial Results for the Fourth Quarter & Fiscal Year 2015 31 Jul 2015 9:30AM $7.520 $29.790 risen by 296.14%
$17,695 Q4 & Fiscal Year-End, 2015 Results Conference Call 3 Jul 2015 9:47AM $7.260 $29.790 risen by 310.33%
$17,695 ResMed FORM SD 28 May 2015 11:09AM $7.460 $29.790 risen by 299.33%
$17,695 EXCHANGE RATE FOR UPCOMING DIVIDEND PAYMENT 25 May 2015 12:31PM $7.300 $29.790 risen by 308.08%
$17,695 RNO: ResMed Inc to sell Mute snoring & sleep technology 15 May 2015 9:20AM $6.730 $29.790 risen by 342.64%
$17,695 Form 8-K 14 May 2015 9:04AM $8.250 $29.790 risen by 261.09%
$17,695 Appendix 3B 30 Apr 2015 10:13AM $8.020 $29.790 risen by 271.45%
$17,695 Form 10Q for QTR ended March 31, 2015 30 Apr 2015 9:22AM $8.020 $29.790 risen by 271.45%
$17,695 Financial Results for Quarter Ended March 31, 2015 24 Apr 2015 9:40AM $9.370 $29.790 risen by 217.93%
$17,695 Form 10Q for QTR ended December 31, 2014 2 Feb 2015 9:42AM $7.970 $29.790 risen by 273.78%
$17,695 RESMED TO ANNOUNCE SECOND QUARTER 2015 RESULTS 23 Jan 2015 9:38AM $7.380 $29.790 risen by 303.66%
$17,695 Financial Results for Quarter Ended September 30, 2014 24 Oct 2014 9:40AM $5.370 $29.790 risen by 454.75%
$17,695 Financial Results For 4th Qtr 14 & Fiscal Year 2014 1 Aug 2014 9:45AM $5.230 $29.790 risen by 469.60%
$17,695 Record Financial Results for Quarter Ended March 31,2014 24 Apr 2014 8:41AM $5.260 $29.790 risen by 466.35%
$17,695 Form 8 - K 28 Feb 2014 9:59AM $4.900 $29.790 risen by 507.96%

601 - 625 of 703 results

Page 25 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.